Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America

Disclosure:"This posts contain affiliate links to Amazon.com. As an Amazon Associate, I earn from qualifying purchases".
ebooksmd.com doesn't sell or deliver any of the products listed on our site. Instead, we list information about books that can be purchased from Amazon.com. We work hard to make sure that the information presented on our site is complete and accurate.
Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America | | 4.5